Hostname: page-component-5cf477f64f-xc2pj Total loading time: 0 Render date: 2025-03-31T04:25:15.027Z Has data issue: false hasContentIssue false
  • English
  • Français

Malaria in the Asia-Pacific Region

Published online by Cambridge University Press:  14 March 2025

J. Kevin Baird
Get access Rights & Permissions [Opens in a new window]

Summary

Despite its relative invisibility to most people living in the urban Asia-Pacific, endemic malaria occurs across the region. The unique character of Asian-Pacific malaria includes a serious problem of drug resistance, dominance of a particularly difficult species to control and treat, and another that normally dwells in monkeys but often infects humans. Most nations in the region with endemic malaria have called for its elimination by the year 2030. Meeting that ambitious goal will require mobilizing technical and financial resources, and social and political will. Malaria is a formidable foe fully capable of defeating halfhearted efforts to eliminate it.

Keywords

Malariapublic healthcontroltreatmentelimination
Type
Research Article
Information
Asia-Pacific Journal , Volume 13 , Issue 45 , November 2015 , e1
Copyright
Copyright © The Authors 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

World Health Organization. World Malaria Report 2014. Geneva.Google Scholar
Hay, SI, Gething, PW, Snow, RW. India's invisible malaria burden. Lancet 2010; 376: 177–17.Google Scholar
Mueller, I, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infectious Diseases 2009; 9: 555–66.Google Scholar
Ibid, WHOGoogle Scholar
Ibid, Hay SI, Gething PW, Snow RWGoogle Scholar
Coatney, GR. Pitfalls in a discovery: the chronicle of chloroquine. American Journal of Tropical Medicine and Hygiene 1963; 12: 121–8.Google Scholar
Attaran, A, et al. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 2004; 363: 233–40.Google Scholar
Tu, Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nature Medicine 2011; 17: 122–20.Google Scholar
See here.Google Scholar
Murray, CJ, et al. Global, regional and national incidence of mortality for HIV, tuberculosis, and malaria during 1990-2013. Lancet 2014; 384: 100–70.Google Scholar
Baird, JK. Resistance to therapies for infection by Plasmodium vivax. Clinical Microbiology Reviews 2009; 22: 500–34.Google Scholar
Howes, RE, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic nations: a geostatistical model-based map. Public Library of Science Medicine 2012; 9: e1001339.Google Scholar
World Health Organization. Control and elimination of Plasmodium vivax malaria: a technical brief. Geneva. 2015.Google Scholar
Baird, JK. Evidence and implications of mortality with acute Plasmodium vivax malaria. Clinical Microbiology Reviews 2013; 26: 36–57.Google Scholar
Baird, JK. Malaria zoonoses. Travel Medicine Infectious Diseases 2009; 8: e2780.Google Scholar
Singh, B, et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 2004; 363: 100–24.Google Scholar
Cox-Singh, J, et al. Plasmodium knowlesi in humans is widely distributed and potentially life threatening. Clinical Infectious Diseases 2008; 46: 166–71.Google Scholar
Malaria: control vs elimination vs eradication. Lancet 2011; 378: 1117.CrossRefGoogle Scholar
See here.Google Scholar
Baird, JK. Resurgent malaria at the millennium: control strategies in crisis. Drugs 2000; 59: 719–43.Google Scholar